NYSE:TMOLife Sciences
Thermo Fisher (TMO) Wins Two FDA Clearances As It Unveils New Diagnostics
Thermo Fisher Scientific showcased multiple new diagnostic solutions at the 2026 Association for Diagnostics & Laboratory Medicine Annual Meeting.
The EXENT Solution secured FDA 510(k) clearance for use in multiple myeloma diagnosis.
The EliA CTD 13 Screen gained FDA clearance for systemic autoimmune connective tissue diseases.
The company also highlighted previously cleared assays for rapid oncology and preeclampsia testing and previewed new digital tools for lab workflow efficiency.
For...